Does PALBOCICLIB Cause Deafness? 198 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 198 reports of Deafness have been filed in association with PALBOCICLIB (Ibrance). This represents 0.2% of all adverse event reports for PALBOCICLIB.
198
Reports of Deafness with PALBOCICLIB
0.2%
of all PALBOCICLIB reports
9
Deaths
15
Hospitalizations
How Dangerous Is Deafness From PALBOCICLIB?
Of the 198 reports, 9 (4.5%) resulted in death, 15 (7.6%) required hospitalization.
Is Deafness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 198 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Deafness?
ADALIMUMAB (1,300)
METHOTREXATE (635)
ETANERCEPT (629)
SACUBITRIL\VALSARTAN (471)
APIXABAN (455)
LENALIDOMIDE (397)
TOFACITINIB (388)
CISPLATIN (344)
AMIKACIN (320)
ATORVASTATIN (308)
Which PALBOCICLIB Alternatives Have Lower Deafness Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID